Giuseppe Curigliano

European Institute of Oncology

Papers

1

Total Citations

178

H-Index

1

About

Giuseppe Curigliano is a leading oncologist whose research has reshaped the surgical and therapeutic landscape of breast cancer. His pioneering work in robotic surgery, particularly the development of robotic nipple-sparing mastectomy with immediate reconstruction, has demonstrated remarkable feasibility and safety, offering patients a less invasive option with superior cosmetic outcomes. This landmark study, cited over 178 times, has established a new paradigm in oncoplastic surgery. Beyond the operating room, Curigliano has made profound contributions to precision oncology, driving advances in molecular profiling and targeted therapies for breast cancer. His research has been instrumental in identifying biomarkers that guide treatment selection, improving survival rates for patients with aggressive subtypes. With an extensive publication record and thousands of citations, Curigliano’s work bridges surgical innovation and systemic therapy, influencing clinical guidelines worldwide. He has also been a key voice in international consensus panels, shaping standards for multidisciplinary breast cancer care. His career exemplifies a commitment to translating cutting-edge science into tangible patient benefits, making him a transformative figure in modern oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
178
Total Citations
178
Avg Citations/Paper
🏆 Most Cited Paper
Robotic nipple-sparing mastectomy for the treatment of breast cancer: Feasibility and safety study
178 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: European Institute of Oncology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago